Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity

This article has been updated

Summary

Steroids are essential for the control of oedema in human malignant glioma patients but may interfere with the efficacy of chemotherapy. Boswellic acids are phytotherapeutic anti-inflammatory agents that may be alternative drugs to corticosteroids in the treatment of cerebral oedema. Here, we report that boswellic acids are cytotoxic to malignant glioma cells at low micromolar concentrations. In-situ DNA end labelling and electron microscopy reveal that boswellic acids induce apoptosis. Boswellic acid-induced apoptosis requires protein, but not RNA synthesis, and is neither associated with free radical formation nor blocked by free radical scavengers. The levels of BAX and BCL-2 proteins remain unaltered during boswellic acid-induced apoptosis. p21 expression is induced by boswellic acids via a p53-independent pathway. Ectopic expression of wild-type p53 also induces p21, and facilitates boswellic acid-induced apoptosis. However, targeted disruption of the p21 genes in colon carcinoma cells enhances rather than decreases boswellic acid toxicity. Ectopic expression of neither BCL-2 nor the caspase inhibitor, CRM-A, is protective. In contrast to steroids, subtoxic concentrations of boswellic acids do not interfere with cancer drug toxicity of glioma cells in acute cytotoxicity or clonogenic cell death assays. Also, in contrast to steroids, boswellic acids synergize with the cytotoxic cytokine, CD95 ligand, in inducing glioma cell apoptosis. This effect is probably mediated by inhibition of RNA synthesis and is not associated with changes of CD95 expression at the cell surface. Further studies in laboratory animals and in human patients are required to determine whether boswellic acids may be a useful adjunct to the medical management of human malignant glioma.

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  1. Ammon, H. P. T. (1996). Salai Guggal-Boswellia serrata: From a herbal medicine to a non redox inhibitor of leukotriene biosynthesis. Eur J Med Res 1: 369–370.

    CAS  PubMed  Google Scholar 

  2. Böker, D. K. & Winking, M. (1997). Die Rolle von Boswellia-Säuren in der Therapie maligner Gliome. Deutsches Ärzteblatt 94: B958–B960.

    Google Scholar 

  3. Gomez-Manzano, C., Fueyo, J., Kyritsis, A. P., McDonnell, T. J., Steck, P. A., Levin, V. A. & Yung, W. K. A. (1997). Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J Natl Cancer Inst 89: 1036–1044.

    CAS  Article  Google Scholar 

  4. Gupta, I., Parihar, A., Malhotra, P., Singh, G. B., Lüdtke, R., Safayhi, H. & Ammon, H. P. T. (1997). Effects of boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res 2: 37–43.

    CAS  PubMed  Google Scholar 

  5. Heldt, R. M., Syrovets, T., Winking, M., Sailer, E. R., Safayhi, H., Ammon, H. P. T. & Simmet, T. H. (1997). Boswellic acids exhibit cytotoxic effects on brain tumor cells independent from 5-lipoxygenase inhibition. Naunyn-S-Arch Pharmacol 355: 30 (Abstract)

  6. Hoernlein, R. F., Orlikowsky, T. H., Niethammer, D., Sailer, E-R, Dannecker, G. E. & Ammon, H. P. T. (1997). Acetyl-11-keto-β-boswellic acid (AKBA) induces apoptosis in HL60 and CCRF-CEM cells and inhibits topoisomerase I. Soc Cancer Res 1291: (Abstract)

  7. Jung, J. M., Bruner, J. M., Ruan, S., Langford, L. A., Kyritsis, A. P., Kobayashi, T., Levin, V. A. & Zhang, W. (1995). Increased levels of p21WAF1/Cip1 in human brain tumors. Oncogene 11: 2021–2028.

    CAS  PubMed  Google Scholar 

  8. Michalowitz, D., Halevy, O. & Oren, M. (1990). Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62: 674–680.

    Google Scholar 

  9. Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E. & Givol, D. (1994). Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54: 3391–3395.

    CAS  PubMed  Google Scholar 

  10. Naumann, U., Durka, S. & Weller, M. (1998). Dexamethasone-mediated protection from drug toxicity linked to p21WAF/CIP1 protein accumulation. Oncogene 17: 1567–1575.

    CAS  Article  Google Scholar 

  11. Roth, W., Fontana, A., Trepel, M., Dichgans, J., Reed, J. C. & Weller, M. (1997). Immunochemotherapy of malignant glioma: synergistic activity of CD95 ligand and chemotherapeutics. Cancer Immunol Immunother 44: 55–63.

    CAS  Article  Google Scholar 

  12. Reber, U., Wüllner, U., Trepel, M., Baumgart, J., Seyfried, J., Klockgether, T., Dichgans, J. & Weller, M. (1998). Potentiation of treosulfan toxicity by the glutathione-depleting agent, buthionine sulfoximine, in human malignant glioma cells: the role of bcl-2. Biochem Pharmacol 55: 349–359.

    CAS  Article  Google Scholar 

  13. Rowe, T. C., Chen, G. L., Hsiang, Y. H. & Liu, L. F. (1986). DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. Cancer Res 46: 2021–2026.

    CAS  PubMed  Google Scholar 

  14. Ruan, S., Okcu, M. F., Ren, J. P., Chiao, P., Andreeff, Levin, V. & Zhang, W. (1998). Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Cancer Res 58: 1538–1543.

    CAS  PubMed  Google Scholar 

  15. Safayhi, H., Mack, T., Sabieraj, J. & Ammon, H. P. T. (1992). Boswellic acids: novel, specific non-redox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 261: 1143–1146.

    CAS  PubMed  Google Scholar 

  16. Safayhi, H., Sailer, E. R. & Ammon, H. P. T. (1995). Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-β-boswellic acids. Mol Pharmacol 47: 1212–1216.

    CAS  PubMed  Google Scholar 

  17. Safayhi, H., Rall, B., Sailer, E. R. & Ammon, H. P. T. (1997). Inhibition by boswellic acids of human leukocyte elastase. J Pharmocol Exp Ther 281: 460–463.

    CAS  Google Scholar 

  18. Sailer, E. R., Subramanian, L. R., Rall, B., Hoernlein, R. F., Ammon, H. P. T. & Safayhi, H. (1996). Acetyl-11-keto-β-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity. Br J Pharmacol 117: 615–618.

    CAS  Article  Google Scholar 

  19. Schulz, J. B., Weller, M. & Klockgether, T. (1996). A sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and free radicals in potassium deprivation-induced apoptosis of cerebellar granule cells. J Neurosci 16: 4696–4706.

    CAS  Article  Google Scholar 

  20. Sheikh, M., Chen, Y. Q., Smith, M. L. & Fornace, A. J. (1997). Role of p21Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells. Oncogene 14: 1875–1882.

    CAS  Article  Google Scholar 

  21. Strasser, A., Harris, A. W., Huang, D. C., Krammer, P. H. & Cory, S. (1995). Bcl-2 and Fas/Apo-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 14: 6136–6147.

    CAS  Article  Google Scholar 

  22. Trepel, M., Groscurth, P., Malipiero, U., Gulbins, E., Dichgans, J. & Weller, M. (1998). Chemosensitivity of human malignant glioma: modulation by p53 gene transfer. J Neuro-Oncol 39: 19–32.

    CAS  Article  Google Scholar 

  23. Van Meir, E. G., Kikuchi, T., Tada, M., Li, H., Diserens, A. C., Wojcik, B. E., Huang, H. J. S., Friedmann, T., De Tribolet, N. & Cavenee, W. K. (1994). Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res 54: 649–652.

    CAS  PubMed  Google Scholar 

  24. Wagenknecht, B., Gulbins, E., Lang, F., Dichgans, J. & Weller, M. (1997a). Lipoxygenase inhibitors block CD95 ligand-mediated apoptosis of human malignant glioma cells. FEBS Lett 409: 17–23.

    CAS  Article  Google Scholar 

  25. Wagenknecht, B., Trepel, M., von Deimling, A., Grimmel, C., Rollbrocker, B., Hayashi, Y., Lang, F., Dichgans, J., Gulbins, E. & Weller, M. (1997b). p53 accumulation promotes dephosphorylation and proteolytic cleavage of retinoblastoma protein in human malignant glioma cells. Cell Physiol Biochem 7: 304–311.

    CAS  Article  Google Scholar 

  26. Wagenknecht, B., Schulz, J. B., Gulbins, E. & Weller, M. (1998). CD95L-induced apoptosis of malignant glioma cells: inhibition of the cascade by crm-A, bcl-2, and NDGA. Cell Death Differ 5: 894–900.

    CAS  Article  Google Scholar 

  27. Waldman, T., Kinzler, K. W. & Vogelstein, B. (1995). p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55: 5187–5190.

    CAS  PubMed  Google Scholar 

  28. Waldman, T., Lengauer, C., Kinzler, K. W. & Vogelstein, B. (1996). Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713–716.

    CAS  Article  Google Scholar 

  29. Weller, M., Frei, K., Groscurth, P., Krammer, P. H., Yonekawa, Y. & Fontana, A. (1994). Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human malignant glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94: 954–964.

    CAS  Article  Google Scholar 

  30. Weller, M., Malipiero, U. V., Aguzzi, A., Reed, J. C. & Fontana, A. (1995a). Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest 95: 2633–2643.

    CAS  Article  Google Scholar 

  31. Weller, M., Malipiero, U., Rensing-Ehl, A., Barr, P. & Fontana, A. (1995b). Fas/APO-1 gene transfer for human malignant glioma. Cancer Res 55: 2936–2944.

    CAS  PubMed  Google Scholar 

  32. Weller, M., Schmidt, C., Roth, W. & Dichgans, J. (1997a). Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone?. Neurology 48: 1704–1709.

    CAS  Article  Google Scholar 

  33. Weller, M., Trepel, M., Grimmel, C., Schabet, M., Bremen, D., Krajewski, S. & Reed, J. C. (1997b). Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. Neurol Res 19: 459–470.

    CAS  Article  Google Scholar 

  34. Weller, M., Winter, S., Schmidt, C., Esser, P., Fontana, A., Dichgans, J. & Groscurth, P. (1997c). Topoisomerase I inhibitors for human malignant glioma. Differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and β-lapachone. Int J Cancer 73: 707–714.

    CAS  Article  Google Scholar 

  35. Weller, M., Rieger, J., Grimmel, C., Van Meir, E. G., De Tribolet, N., Krajewski, S., Reed, J. C., von Deimling, A. & Dichgans, J. (1998). Predicting chemoresistence in human malignant glioma cells: the role of molecular genetic analyses. Int J Cancer 79: 640–644.

    CAS  Article  Google Scholar 

  36. Winking, M., Sarikya, S., Jödicke, A. & Böker, D. K. (1998). Boswellic acids inhibit glioma growth. J Cancer Res Clin Oncol 124: R141 (Abstr.)

  37. Winter, S., Roth, W., Dichgans, J. & Weller, M. (1998). Synergy of CD95 ligand and teniposide: no role of cleavable complex formation and enhanced CD95 expression. Eur J Pharmacol 341: 323–328.

    CAS  Article  Google Scholar 

  38. Winter, S. & Weller, M. (1998). Potentiation of CD95L-induced apoptosis of human malignant glioma cells by topotecan involves inhibition of RNA synthesis but not changes in CD95 or CD95L expression. J Pharmacol Exp Ther 286: 1374–1382.

    CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and Permissions

About this article

Cite this article

Glaser, T., Winter, S., Groscurth, P. et al. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. Br J Cancer 80, 756–765 (1999). https://doi.org/10.1038/sj.bjc.6690419

Download citation

Keywords

  • pentacyclic triterpenes
  • apoptosis
  • chemotherapy
  • brain tumour
  • glioma cells

Search

Quick links